tirzepatide news october 18 2025

tirzepatide news october 18 2025 FDA Grants a New Indication for Obesity Management Tirzepatide GLP-1 medication is known

Name: tirzepatide news october 18 2025 FDA Grants a New Indication for Obesity Management Tirzepatide GLP-1 medication is known
Brand: 2m-capital.com
SKU: 40291735649
Price: 21.91 USD
Availability: InStock
Rating: 4.4275 (8 reviews)

SKU: 40291735649

4.4

EUR21.91 EUR61.91

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 8 - Nov 13

Description

Clinically, patients report greater satiety and reduced hunger, even during significant weight loss

After 68 weeks on semaglutide 2.4 mg, roughly 86% of participants in STEP-1 had lost at least 5% of body weight, but that means 14% did not reach even that modest threshold

Zepbound contains the same active ingredient, tirzepatide, but the FDA specifically approves it for chronic weight management